{"id":28711,"date":"2012-01-26T17:02:49","date_gmt":"2012-01-26T16:02:49","guid":{"rendered":"https:\/\/www.abcsg.org\/?page_id=28711"},"modified":"2021-02-15T08:46:07","modified_gmt":"2021-02-15T07:46:07","slug":"abcsg-publications-peer-reviewed-2001-2005","status":"publish","type":"page","link":"https:\/\/www.abcsg.org\/en\/veroeffentlichungen\/publications\/abcsg-publications-peer-reviewed-2001-2005\/","title":{"rendered":"ABCSG-Publications (peer reviewed) 2001-2005"},"content":{"rendered":"<div class=\"su-accordion su-u-trim\">\n<div class=\"su-spoiler su-spoiler-style-fancy su-spoiler-icon-chevron\" data-scroll-offset=\"0\" data-anchor-in-url=\"no\"><div class=\"su-spoiler-title\" tabindex=\"0\" role=\"button\"><span class=\"su-spoiler-icon\"><\/span>2005<\/div><div class=\"su-spoiler-content su-u-clearfix su-u-trim\">\n<h4>Clinical role of multidrug resistance protein 1 expression in chemotherapy resistance in early-stage breast cancer: the Austrian Breast and Colorectal Cancer Study Group<\/h4>\n<p>Filipits M, Pohl G, Rudas M, Dietze O, Lax S, Grill R, Pirker R, Zielinski C, Hausmaninger H, Kubista E, Samonigg H, Jakesz R<\/p>\n<p>Journal of Clinical Oncology<\/p>\n<p><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15718312\">https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15718312<\/a><\/p>\n<hr \/>\n<h4>Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2 years&#8217; adjuvant tamoxifen: combined results of ABCSG trial 8 and ARNO 95 trial<\/h4>\n<p>Jakesz R, Jonat W, Gnant M, Mittlb\u00f6ck M, Greil R, Tausch Ch, Hilfrich J, Kwasny W, Menzel Ch, Samonigg H, Seifer M, Gademann G, Kaufmann M<\/p>\n<p>The Lancet<\/p>\n<p><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16084253\">https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16084253<\/a><\/p>\n<hr \/>\n<h4>Trastuzumab after Adjuvant Chemotherapy in HER2-positive Breast Cancer<\/h4>\n<p>Piccart-Gebhart M, Procter M, Leyland-Jones B, Goldhirsch A, Untch M, Smith I, Gianni L, Baselga J, Bell R, Jackisch C, Cameron D, Dowsett M, Barrios C, Steger G, Huang C, Andersson M, Inbar M, Lichinitser M, L\u00e1ng I, Nitz U, Iwata H, Thomssen C, Lorisch C, Suter T, R\u00fcschoff J, S\u00fct\u00b4\u00f6, Greatorex V, Ward C, Straehle C, McFadden E, Dolci S, Gelber S<\/p>\n<p>The New England Journal of Medicine<\/p>\n<p><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16236737\">https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16236737<\/a><\/p>\n<hr \/>\n<h4>A prospective randomised trial to study the role of levamisole and interferon alfa in an adjuvant therapy with 5-FU for Stage III colon cancer<\/h4>\n<p>Schippinger W, Jagoditsch M, Sorr\u00e9 C, Gnant M, Steger G, Hausmaninger H, Mlineritsch B, Schaberl-Moser R, Mischinger HJ, Hofbauer F, Holzberger P, Mittlb\u00f6ck M, Jakesz R<\/p>\n<p>British Journal of Cancer<\/p>\n<p><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15856042\">https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15856042 <\/a><\/p>\n<\/div><\/div>\n<div class=\"su-spoiler su-spoiler-style-fancy su-spoiler-icon-chevron su-spoiler-closed\" data-scroll-offset=\"0\" data-anchor-in-url=\"no\"><div class=\"su-spoiler-title\" tabindex=\"0\" role=\"button\"><span class=\"su-spoiler-icon\"><\/span>2004<\/div><div class=\"su-spoiler-content su-u-clearfix su-u-trim\">\n<h4>Empfehlungen zu Diagnostik und multimodaler Prim\u00e4rtherapie des Rektumkarzinoms 2004<\/h4>\n<p>ABCSG, ACO\/ASSO, \u00d6GC, \u00d6GHO, \u00d6GP, \u00d6GRO, \u00d6RG<\/p>\n<p>Wiener Klinische Wochenschrift 2004.: 10.1007\/s00508-005-0323-1<\/p>\n<p><a href=\"https:\/\/www.springermedizin.de\/empfehlungen-zu-diagnostik-und-multimodaler-primaertherapie-des-\/8563870\">https:\/\/www.springermedizin.de\/empfehlungen-zu-diagnostik-und-multimodaler-primaertherapie-des-\/8563870<\/a><\/p>\n<hr \/>\n<h4>Amenorrhoea, aromatase inhibitors, tamoxifen or a combination in premenopausal women.<\/h4>\n<p>Jakesz R<\/p>\n<p>European Journal of Cancer<\/p>\n<p><a href=\"https:\/\/cyberleninka.org\/article\/n\/275469\">https:\/\/cyberleninka.org\/article\/n\/275469<\/a><\/p>\n<hr \/>\n<h4>Prognostic value of lymphangiogenesis and lymphovascular invasion in invasive breast cancer.<\/h4>\n<p>Schoppmann SF, Bayer G, Aumayr K, Taucher S, Geleff S, Rudas M, Kubista E, Hausmaninger H, Samonigg H, Gnant M, Jakesz R, Horvat R<\/p>\n<p>Annals of Surgery<\/p>\n<p><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15273556\">https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15273556<\/a><\/p>\n<hr \/>\n<h4>The impact of progesterone receptor in prediction of complete pathological response to preoperative chemotherapy in primary breast cancer patients.<\/h4>\n<p>Taucher S, Rudas M, Gnant M, Dubsky P, Sporn E, Roka S, Bachleitner T, Fitzal F, Kandioler D, Wenzel C, Steger G, Draxler W, Mittlb\u00f6ck M, Jakesz R<\/p>\n<p>European Surgery<\/p>\n<p><a href=\"https:\/\/link.springer.com\/article\/10.1007\/s10353-004-0028-0\">https:\/\/link.springer.com\/article\/10.1007\/s10353-004-0028-0<\/a><\/p>\n<\/div><\/div>\n<div class=\"su-spoiler su-spoiler-style-fancy su-spoiler-icon-chevron su-spoiler-closed\" data-scroll-offset=\"0\" data-anchor-in-url=\"no\"><div class=\"su-spoiler-title\" tabindex=\"0\" role=\"button\"><span class=\"su-spoiler-icon\"><\/span>2003<\/div><div class=\"su-spoiler-content su-u-clearfix su-u-trim\">\n<h4>Incidence of liver metastases in patients receiving adjuvant chemotherapy after lymph node positive primary colon cancer<\/h4>\n<p>Gruenberger T, Schwanzer E, Samonigg H, Hausmaninger H, Jakesz R<\/p>\n<p>Journal of Gastrointestinal Surgery<\/p>\n<hr \/>\n<h4>Pelvic radiological imaging: a surgeon&#8217;s perspective<\/h4>\n<p>Herbst F<\/p>\n<p>European Journal of Radiology<\/p>\n<p><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12880994\">https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12880994<\/a><\/p>\n<hr \/>\n<h4>Significant increase in breast conservation in 16 years of trials conducted by the Austrian Breast &amp; Colorectal Cancer Study Group (ABCSG)<\/h4>\n<p>Jakesz R, Samonigg H, Gnant M, Kubista E, Depisch D, Kolb R, Mlineritsch B, Mischinger HJ, Menzel RC, Steindorfer P, Kwasny W, Tausch C, Stierer M, Taucher S, Seifert M, Hausmaninger H<\/p>\n<p>Annals of Surgery<\/p>\n<p><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC1514470\/\">https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC1514470\/<\/a><\/p>\n<hr \/>\n<h4>In reply to: Paradigm shift in adjuvant treatment of receptor positive premenopausal breast cancer patients? Not yet.<\/h4>\n<p>Jakesz R<\/p>\n<p>Journal of Clinical Oncology<\/p>\n<hr \/>\n<h4>Randomised trial: One cycle of anthracycline-containing adjuvant chemotherapy compared with six cycles of CMF treatment in node-positive, hormone receptor negative breast cancer patients<\/h4>\n<p>Ploner F, Jakesz R, Hausmaninger H, Kolb R, Stierer M, Fridrik M, Steindorfer P, Gnant M, Haider K, Mlineritsch B, Tschurtschenthaler G, Steger G, Seifert M, Kubista E, Samonigg H<\/p>\n<p>Onkologie<\/p>\n<p><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12771518\">https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12771518<\/a><\/p>\n<hr \/>\n<h4>High p27 Kip1 expression predicts superior relapse-free and overall survival for premenopausal women with early-stage breast cancer receiving adjuvant treatment with tamoxifen plus goserelin<\/h4>\n<p>Pohl G, Rudas M, Dietze O, Lax S, Markis E, Pirker R, Zielinski C, Hausmaninger H, Kubista E, Samonigg H, Jakesz R, Filiptis M<\/p>\n<p>Journal of Clinical Oncology<\/p>\n<p><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/14512390\">https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/14512390<\/a><\/p>\n<hr \/>\n<h4>Randomized trial of tamoxifen vs tamoxifen plus aminoglutethimide as adjuvant treatment in postmenopausal breast cancer patients with hormone receptor-positive disease: Austrian Breast and Colorectal Cancer Study Group Trial 6.<\/h4>\n<p>Schmid M, Jakesz R, Samonigg H, Kubista E, Gnant M, Menzel C, Seifert M, Haider K, Taucher S, Mlineritsch B, Steindorfer P, Kwasny W, Stierer M, Tausch C, Fridrik M, Wette V, Steger G, Hausmaninger H<\/p>\n<p>Journal of Clinical Oncology<\/p>\n<p><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12637461\">https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12637461<\/a><\/p>\n<hr \/>\n<h4>Dendritic Cell-Based Vaccination in Solid Cancer<\/h4>\n<p>Stift A, Dubsky P, Bachleitner-Hofmann T, Schueller G, Zontsich T, Benkoe T, Radelbauer K, Brostjan C, Jakesz R, Gnant M<\/p>\n<p>Journal of Clinical Oncology<\/p>\n<p><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12506182\">https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12506182<\/a><\/p>\n<hr \/>\n<h4>Sequential steroid hormone receptor measurements in primary breast cancer with and without intervening primary chemotherapy<\/h4>\n<p>Taucher S, Rudas M, Gnant M, Thomanek K, Dubsky P, Roka S, Bachleitner T, Kandioler D, Wenzel C, Steger G, Mittlb\u00f6ck M, Jakesz R<\/p>\n<p>Endocrine-Related Cancer<\/p>\n<p><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12653672\">https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12653672<\/a><\/p>\n<hr \/>\n<h4>Preventive mastectomy in patients at breast cancer risk due to genetic alterations in the BRCA1 and BRCA2 gene<\/h4>\n<p>Taucher S, Gnant M, Jakesz R<\/p>\n<p>Langenbecks Archive of Surgery<\/p>\n<p><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12690474\">https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12690474<\/a><\/p>\n<hr \/>\n<h4>Overexpression of Id-1 is associated with poor clinical outcome in node negative breast cancer<\/h4>\n<p>Schoppmann SF, Schindl M, Bayer G, Aumayr K, Dienes J, Horvat R, Rudas M, Gnant M, Jakesz R, Birner P<\/p>\n<p>Wiley-Liss DOI 10.1002\/ijc.11009<\/p>\n<p><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12640673\">https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12640673<\/a><\/p>\n<hr \/>\n<h4>Impact of pretreatment thromboyctosis on survival in primary breast cancer<\/h4>\n<p>Taucher S, Salat A, Gnant M, Kwasny W, Mlineritsch B, Menzel RC, Schmid M, Smola MG, Stierer M, Tausch C, Galid A, Steger G, Jakesz R<\/p>\n<p>Thrombosis &amp; Haemostasis<\/p>\n<p><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12783124\">https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12783124<\/a><\/p>\n<\/div><\/div>\n<div class=\"su-spoiler su-spoiler-style-fancy su-spoiler-icon-chevron su-spoiler-closed\" data-scroll-offset=\"0\" data-anchor-in-url=\"no\"><div class=\"su-spoiler-title\" tabindex=\"0\" role=\"button\"><span class=\"su-spoiler-icon\"><\/span>2002<\/div><div class=\"su-spoiler-content su-u-clearfix su-u-trim\">\n<h4>Identification of Sentinel Lymph Nodes in Breast Cancer by Lymphoscintingraphy and Gamma Probe Guidance: Dependence on Route of Injection and Tumour Location<\/h4>\n<p>Gallowitsch JH, Konstantiniuk P, J\u00f6rg L, Urbania A, Kugler F, Peschina W, Hatzl-Griesenhofer M, Zettinig G<\/p>\n<p>European Surgery<\/p>\n<p><a href=\"https:\/\/onlinelibrary.wiley.com\/doi\/abs\/10.1046\/j.1563-2563.2002.02072.x\">https:\/\/onlinelibrary.wiley.com\/doi\/abs\/10.1046\/j.1563-2563.2002.02072.x<\/a><\/p>\n<hr \/>\n<h4>The importance of sentinel node biopsy in breast surgery<\/h4>\n<p>Haid A, Schrenk P, Roka S, Tausch C, Pichler-Gebhard B, Rudas M, Zimmermann G<\/p>\n<p>European Surgery<\/p>\n<p><a href=\"https:\/\/onlinelibrary.wiley.com\/doi\/abs\/10.1046\/j.1563-2563.2002.02065.x\">https:\/\/onlinelibrary.wiley.com\/doi\/abs\/10.1046\/j.1563-2563.2002.02065.x<\/a><\/p>\n<hr \/>\n<h4>Chemotherapy versus hormonal adjuvant treatment in premenopausal patients with breast cancer<\/h4>\n<p>Jakesz R, Hausmaninger H, Samonigg H<\/p>\n<p>European Journal of Cancer<\/p>\n<p><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11818196\">https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11818196<\/a><\/p>\n<hr \/>\n<h4>Randomized adjuvant trial of tamoxifen and goserelin versus cyclophospamide, methotrexate, and fluorouracil: Evidence for the superiority of treatment with endocrine blockade in premenopausal patients with hormone-responsive breast cancer<\/h4>\n<p>Jakesz R, Hausmaninger H, Kubista E, Gnant M, Menzel C, Bauernhofer T, Seifert M, Haider K, Mlineritsch B, Steindorfer P, Kwasny W, Fridrik M, Steger G, Wette V, Samonigg H<\/p>\n<p>Journal of Clinical Oncology<\/p>\n<p><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12488405\">https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12488405<\/a><\/p>\n<hr \/>\n<h4>Standards in der Mamma-Ca-Therapie<\/h4>\n<p>Jakesz R<\/p>\n<p>Wiener Klinische Wochenschrift<\/p>\n<hr \/>\n<h4>Overexpression of hypoxia-inducible factor 1alpha is associated with an unfavorable prognosis in lymph node-positive breast cancer<\/h4>\n<p>Schindl M, Schoppmann F, Samonigg H, Hausmaninger H, Kwasny W, Gnant M, Jakesz R, Kubista E, Birner P, Oberhuber G<\/p>\n<p>Clinical Cancer Research<\/p>\n<p><a href=\"https:\/\/www.researchgate.net\/publication\/11313017_Overexpression_of_Hypoxia-inducible_Factor_1a_Is_Associated_with_an_Unfavorable_Prognosis_in_Lymph_Node-positive_Breast_Cancer\">https:\/\/www.researchgate.net\/publication\/11313017.. Breast_Cancer<\/a><\/p>\n<hr \/>\n<h4>Survival of women with breast cancer in Austria by age, stage and period of diagnosis<\/h4>\n<p>Vutuc Chr, Waldhoer T, Klimot J, Haidinger G, Jakesz R, Kubist E, Zielinski C<\/p>\n<p>Wiener Klinische Wochenschrift<\/p>\n<p><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12422577\">https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12422577<\/a><\/p>\n<\/div><\/div>\n<div class=\"su-spoiler su-spoiler-style-fancy su-spoiler-icon-chevron su-spoiler-closed\" data-scroll-offset=\"0\" data-anchor-in-url=\"no\"><div class=\"su-spoiler-title\" tabindex=\"0\" role=\"button\"><span class=\"su-spoiler-icon\"><\/span>2001<\/div><div class=\"su-spoiler-content su-u-clearfix su-u-trim\">\n<h4>Evaluation of the United States Food and Drug Administration approved Scoring and Test System of HER-2 Protein Expression in Breast Cancer<\/h4>\n<p>Birner P, Oberhuber G, Stani J, Reithofer C, Samonigg H, Hausmaninger H, Kubista E, Kwasny W, Kandioler-Eckersberger D, Gnant M, Jakesz R<\/p>\n<p>Clinical Cancer Research<\/p>\n<p><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11410505\">https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11410505<\/a><\/p>\n<hr \/>\n<h4>Prognostic relevance of three histological grading methods in breast cancer<\/h4>\n<p>Latinovic L, Heinze G, Birner P, Samonigg H, Hausmaninger H, Kubista E, Kwasny W, Gnant M, Jakesz R, Oberhuber G<\/p>\n<p>International Journal of Oncology<\/p>\n<p><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11713599\">https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11713599<\/a><\/p>\n<\/div><\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":0,"parent":28699,"menu_order":440,"comment_status":"closed","ping_status":"closed","template":"page-publikationen.php","meta":{"_acf_changed":false,"footnotes":""},"tags":[],"class_list":["post-28711","page","type-page","status-publish","hentry"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-10-08 01:14:43","action":"delete","newStatus":"draft","terms":[],"taxonomy":"translation_priority","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/www.abcsg.org\/en\/wp-json\/wp\/v2\/pages\/28711","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abcsg.org\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.abcsg.org\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.abcsg.org\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abcsg.org\/en\/wp-json\/wp\/v2\/comments?post=28711"}],"version-history":[{"count":1,"href":"https:\/\/www.abcsg.org\/en\/wp-json\/wp\/v2\/pages\/28711\/revisions"}],"predecessor-version":[{"id":28736,"href":"https:\/\/www.abcsg.org\/en\/wp-json\/wp\/v2\/pages\/28711\/revisions\/28736"}],"up":[{"embeddable":true,"href":"https:\/\/www.abcsg.org\/en\/wp-json\/wp\/v2\/pages\/28699"}],"wp:attachment":[{"href":"https:\/\/www.abcsg.org\/en\/wp-json\/wp\/v2\/media?parent=28711"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abcsg.org\/en\/wp-json\/wp\/v2\/tags?post=28711"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}